Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of F-star Therapeutics, Inc. (SBPH) since 2016 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of F-star Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1566373.
Total stock buying since 2016: $2,491,907.
Total stock sales since 2016: $63,676.
Total stock option exercises since 2016: $37,135.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2022 | 0 | $0 | 0 | $0 | 337,596 | $37,135 |
| 2021 | 0 | $0 | 1,182 | $9,784 | 0 | $0 |
| 2020 | 0 | $0 | 700 | $3,332 | 25,000 | $0 |
| 2019 | 52,000 | $272,230 | 40,000 | $50,560 | 0 | $0 |
| 2018 | 5,000 | $60,910 | 0 | $0 | 0 | $0 |
| 2017 | 83,623 | $1,080,676 | 0 | $0 | 0 | $0 |
| 2016 | 95,066 | $1,078,091 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2022-07 | 0 | $0 | 0 | $0 | 337,596 | $37,135 |
| 2021-11 | 0 | $0 | 64 | $437 | 0 | $0 |
| 2021-10 | 0 | $0 | 64 | $462 | 0 | $0 |
| 2021-07 | 0 | $0 | 1,054 | $8,885 | 0 | $0 |
| 2020-11 | 0 | $0 | 700 | $3,332 | 25,000 | $0 |
| 2019-12 | 0 | $0 | 40,000 | $50,560 | 0 | $0 |
| 2019-11 | 10,000 | $29,350 | 0 | $0 | 0 | $0 |
| 2019-06 | 12,000 | $49,080 | 0 | $0 | 0 | $0 |
| 2019-05 | 20,000 | $120,450 | 0 | $0 | 0 | $0 |
| 2019-04 | 10,000 | $73,350 | 0 | $0 | 0 | $0 |
| 2018-08 | 4,000 | $48,080 | 0 | $0 | 0 | $0 |
| 2018-02 | 1,000 | $12,830 | 0 | $0 | 0 | $0 |
| 2017-09 | 1,000 | $14,840 | 0 | $0 | 0 | $0 |
| 2017-08 | 4,500 | $55,322 | 0 | $0 | 0 | $0 |
| 2017-06 | 76,923 | $999,999 | 0 | $0 | 0 | $0 |
| 2017-02 | 1,200 | $10,515 | 0 | $0 | 0 | $0 |
| 2016-12 | 2,000 | $17,000 | 0 | $0 | 0 | $0 |
| 2016-11 | 11,000 | $94,470 | 0 | $0 | 0 | $0 |
| 2016-09 | 6,400 | $79,250 | 0 | $0 | 0 | $0 |
| 2016-08 | 21,500 | $237,379 | 0 | $0 | 0 | $0 |
| 2016-05 | 54,166 | $649,992 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-07-29 | Forster Eliot (President and CEO) | Option Ex | 260,977 | .11 | 28,707 |
| 2022-07-29 | Brewis Neil (Chief Scientific Officer) | Option Ex | 76,619 | .11 | 8,428 |
| 2021-11-02 | Kayitalire Louis (Chief Medical Officer) | Sale | 64 | 6.83 | 437 |
| 2021-10-04 | Kayitalire Louis (Chief Medical Officer) | Sale | 64 | 7.23 | 462 |
| 2021-07-02 | Kayitalire Louis (Chief Medical Officer) | Sale | 1,054 | 8.43 | 8,885 |
| 2020-11-20 | Firmani Lori (VP of Finance and Treasurer) | Sale | 175 | 4.76 | 833 |
| 2020-11-20 | Winslow Garrett (General Counsel and Secretary) | Sale | 175 | 4.76 | 833 |
| 2020-11-20 | Iyer Radhakrishnan P. (Chief Scientific Officer) | Sale | 175 | 4.76 | 833 |
| 2020-11-20 | Driscoll Martin J (President and CEO) | Sale | 175 | 4.76 | 833 |
| 2020-11-19 | Firmani Lori (VP of Finance and Treasurer) | Option Ex | 3,750 | .00 | 0 |
| 2020-11-19 | Winslow Garrett (General Counsel and Secretary) | Option Ex | 6,250 | .00 | 0 |
| 2020-11-19 | Iyer Radhakrishnan P. (Chief Scientific Officer) | Option Ex | 5,000 | .00 | 0 |
| 2020-11-19 | Driscoll Martin J (President and CEO) | Option Ex | 10,000 | .00 | 0 |
| 2019-12-30 | Eichler Kurt M (Director) | Sale | 40,000 | 1.26 | 50,560 |
| 2019-11-14 | Freve Jonathan (CFO & Treasurer) | Buy | 5,000 | 3.04 | 15,200 |
| 2019-11-13 | Driscoll Martin J (President and CEO) | Buy | 5,000 | 2.83 | 14,150 |
| 2019-06-28 | Smith Scott Andrew (Director) | Buy | 12,000 | 4.09 | 49,080 |
| 2019-05-29 | Freve Jonathan (CFO & Treasurer) | Buy | 5,000 | 5.40 | 27,000 |
| 2019-05-29 | Driscoll Martin J (President and CEO) | Buy | 10,000 | 6.03 | 60,300 |
| 2019-05-21 | Driscoll Martin J (President and CEO) | Buy | 5,000 | 6.63 | 33,150 |
| 2019-04-30 | Driscoll Martin J (President and CEO) | Buy | 10,000 | 7.33 | 73,350 |
| 2018-08-13 | Driscoll Martin J (President and CEO) | Buy | 4,000 | 12.02 | 48,080 |
| 2018-02-28 | Driscoll Martin J (President and CEO) | Buy | 1,000 | 12.83 | 12,830 |
| 2017-09-14 | Driscoll Martin J (President and CEO) | Buy | 1,000 | 14.84 | 14,840 |
| 2017-08-04 | Arkowitz David (Director) | Buy | 2,500 | 12.24 | 30,612 |
| 2017-08-03 | Driscoll Martin J (President and CEO) | Buy | 2,000 | 12.36 | 24,710 |
| 2017-06-27 | Eichler Kurt M (Director) | Buy | 76,923 | 13.00 | 999,999 |
| 2017-02-23 | Eichler Kurt M (Director) | Buy | 1,200 | 8.76 | 10,515 |
| 2016-12-15 | Driscoll Martin J (President and CEO) | Buy | 2,000 | 8.50 | 17,000 |
| 2016-11-30 | Driscoll Martin J (President and CEO) | Buy | 2,000 | 7.98 | 15,960 |
| 2016-11-09 | Eichler Kurt M (Director) | Buy | 7,000 | 8.69 | 60,830 |
| 2016-11-09 | Driscoll Martin J (President and CEO) | Buy | 2,000 | 8.84 | 17,680 |
| 2016-09-19 | Eichler Kurt M (Director) | Buy | 1,346 | 12.50 | 16,825 |
| 2016-09-16 | Eichler Kurt M (Director) | Buy | 650 | 12.50 | 8,125 |
| 2016-09-14 | Eichler Kurt M (Director) | Buy | 514 | 12.50 | 6,425 |
| 2016-09-13 | Eichler Kurt M (Director) | Buy | 490 | 12.50 | 6,125 |
| 2016-09-09 | Afdhal Nezam H. (Chief Medical Officer) | Buy | 2,400 | 12.50 | 30,000 |
| 2016-09-02 | Driscoll Martin J (President and CEO) | Buy | 1,000 | 11.75 | 11,750 |
| 2016-08-30 | Driscoll Martin J (President and CEO) | Buy | 1,000 | 12.41 | 12,410 |
| 2016-08-24 | Afdhal Nezam H. (Chief Medical Officer) | Buy | 2,000 | 11.96 | 23,926 |
| 2016-08-23 | Freve Jonathan (CFO, Treasurer & Secretary) | Buy | 1,000 | 10.74 | 10,740 |
| 2016-08-23 | Eichler Kurt M (Director) | Buy | 3,000 | 10.73 | 32,190 |
| 2016-08-22 | Driscoll Martin J (President and CEO) | Buy | 1,000 | 11.66 | 11,660 |
| 2016-08-19 | Driscoll Martin J (President and CEO) | Buy | 1,000 | 11.20 | 11,200 |
| 2016-08-16 | Afdhal Nezam H. (Chief Medical Officer) | Buy | 100 | 11.49 | 1,149 |
| 2016-08-16 | Driscoll Martin J (President and CEO) | Buy | 1,000 | 11.37 | 11,370 |
| 2016-08-15 | Afdhal Nezam H. (Chief Medical Officer) | Buy | 1,800 | 11.43 | 20,574 |
| 2016-08-15 | Driscoll Martin J (President and CEO) | Buy | 1,000 | 11.20 | 11,200 |
| 2016-08-12 | Afdhal Nezam H. (Chief Medical Officer) | Buy | 2,600 | 11.33 | 29,450 |
| 2016-08-09 | Driscoll Martin J (President and CEO) | Buy | 2,000 | 11.03 | 22,050 |
| 2016-08-04 | Freve Jonathan (CFO, Treasurer & Secretary) | Buy | 1,000 | 9.75 | 9,750 |
| 2016-08-04 | Eichler Kurt M (Director) | Buy | 1,000 | 9.79 | 9,790 |
| 2016-08-04 | Driscoll Martin J (President and CEO) | Buy | 2,000 | 9.96 | 19,920 |
| 2016-05-11 | Eichler Kurt M (Director) | Buy | 41,666 | 12.00 | 499,992 |
| 2016-05-11 | Driscoll Martin J (President and CEO) | Buy | 12,500 | 12.00 | 150,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of SBPH listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of F-star Therapeutics, Inc. (symbol SBPH, CIK number 1566373) see the Securities and Exchange Commission (SEC) website.